Related Experiment Video

Updated: Jun 13, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?

Barbara Ingold1, Eva Simon, Ute Ungethüm

  • 1Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany.

Plos One
|April 14, 2010
PubMed
Abstract

Insights

This study found that the CXCL12-CXCR4 pathway is involved in gastric cancer progression and may be a target for anti-angiogenic therapy. Further research is needed to explore its therapeutic potential in gastric carcinomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • G-protein-coupled receptors (GPCRs) are crucial in cancer development and present therapeutic targets.
  • Gastric carcinomas, particularly node-positive cases, require further investigation for differentially expressed GPCRs.

Purpose of the Study:

  • To identify and analyze differentially expressed GPCRs in node-positive gastric carcinomas.
  • To investigate the role of the CXCL12-CXCR4 pathway in gastric cancer biology and its potential as an antiangiogenic target.

Main Methods:

  • Gene array technology was used to analyze GPCR expression in gastric carcinomas.
  • Real-time RT-PCR validated CXCL12 and CXCR4 expression in an independent cohort.
  • Immunohistochemistry assessed protein expression in tumor tissues and lymph node metastases, correlating with clinicopathological data and survival.

Main Results:

  • 52 GPCRs were differentially expressed in node-positive gastric cancer, including CXCL12.
  • CXCL12 expression correlated with local tumor growth but not survival.
  • Vascular CXCR4 expression was linked to increased local tumor extent and advanced UICC stages.

Conclusions:

  • GPCRs play a significant role in gastric carcinoma biology.
  • The CXCL12-CXCR4 pathway shows promise as a novel antiangiogenic therapeutic target for gastric carcinomas.

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...